Kurl R N, Morris I D
Br J Pharmacol. 1978 Apr;62(4):487-93. doi: 10.1111/j.1476-5381.1978.tb07752.x.
1 The in vivo actions of the oestrogen antagonists, MER-25 and tamoxifen upon the cytosol oestrogen receptors prepared from amygdala, hypothalamus, pituitary and uterus of rats were studied 24 h after drug administration. 2 There was a dose-related depletion of cytosol oestrogen receptors. However, the uterine and pituitary receptors were consistently affected at a lower dose than were those from the brain. 3 The ratios of the combined central ED50 to the combined peripheral ED50 were clomiphene 169 greater than MER-25 19.2 greater than tamoxifen 2.13. 4 The receptor changes were not related to biological activity monitored by serum luteinizing hormone levels and uterotrophic response. 5 The possible role of these drug effects in the induction of ovulation and future developments are discussed.
研究了雌激素拮抗剂MER - 25和他莫昔芬在给药24小时后对从大鼠杏仁核、下丘脑、垂体和子宫制备的胞浆雌激素受体的体内作用。
胞浆雌激素受体出现了剂量相关的耗竭。然而,子宫和垂体受体受到影响的剂量始终低于脑内受体。
联合中枢ED50与联合外周ED50的比值为:氯米芬169大于MER - 25 19.2大于他莫昔芬2.13。
受体变化与通过血清促黄体生成素水平和子宫营养反应监测的生物学活性无关。
讨论了这些药物作用在诱导排卵及未来发展中的可能作用。